The Effectiveness of Bacillus Calmette-Guerin (BCG) Maintenance Treatment in Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

被引：0
|
作者：
Kim, B. [1 ]
Ha, J. [1 ]
Park, C. [1 ]
Kim, C. [1 ]
机构：
[1] Keimyung Univ, Dept Urol, Sch Med, Daegu, South Korea
来源：
UROLOGY | 2012年 / 80卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
EP.075
引用
收藏
页码：S215 / S216
页数：2
相关论文
共 50 条
  • [1] The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
    Gontero, Paolo
    Bohle, Andreas
    Malmstrom, Per-Uno
    O'Donnell, Michael A.
    Oderda, Marco
    Sylvester, Richard
    Witjes, Fred
    [J]. EUROPEAN UROLOGY, 2010, 57 (03) : 410 - 429
  • [2] Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    Dalbagni, Guido
    Donat, Sherri M.
    [J]. EUROPEAN UROLOGY, 2011, 60 (01) : 32 - 36
  • [3] Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
    Tan, Wei Shen
    Grajales, Valentina
    Bree, Kelly
    Li, Roger
    Nogueras-Gonzalez, Graciela M.
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish M.
    [J]. BJU INTERNATIONAL, 2023, 132 (04) : 384 - 386
  • [4] Maintenance Bacillus Calmette-Guerin Treatment of Non-muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence
    Ehdaie, Behfar
    Sylvester, Richard
    Herr, Harry W.
    [J]. EUROPEAN UROLOGY, 2013, 64 (04) : 579 - 585
  • [5] Maintenance Bacillus Calmette-Guerin: The Standard of Care for the Prophylaxis and Management of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer
    Lamm, Donald
    Persad, Raj
    Colombel, Marc
    Brausi, Maurizio
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (09) : 715 - 734
  • [6] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [7] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    [J]. CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [8] Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer
    Sharma, Vidit
    Wymer, Kevin M.
    Borah, Bijan J.
    Saigal, Christopher S.
    Litwin, Mark S.
    Packiam, Vignesh T.
    Thompson, R. Houston
    Tollefson, Matthew K.
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (03): : 442 - 449
  • [9] Treatment Options Available for Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer
    Yates, David R.
    Brausi, Maurizio A.
    Catto, James W. F.
    Dalbagni, Guido
    Roupret, Morgan
    Shariat, Shahrokh F.
    Sylvester, Richard J.
    Witjes, J. Alfred
    Zlotta, Alexandre R.
    Palou-Redorta, Juan
    [J]. EUROPEAN UROLOGY, 2012, 62 (06) : 1088 - 1096
  • [10] Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
    Su, Fei
    Liu, Ming
    Zhang, Wei
    Tang, Min
    Zhang, Jinsong
    Li, Hexin
    Zou, Lihui
    Zhang, Rui
    Liu, Yudong
    Li, Lin
    Ma, Jie
    Zhang, Yaqun
    Chen, Meng
    Xiao, Fei
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345